Today is 2 weeks since my second vaccine dose (Astrazeneca/Pfizer)
That means I have maximum protection and am pretty much safe from severe disease, hospitalization and death now. Of course there is a very small chance things could go south but it is negligible. Feels good. Covid anxiety gone.
I’m fully vaccinated, so I no longer wear a mask in most places (my choice).
With the vaccines, I now view COVID-19 as an “acceptable risk.” An acceptable risk is the likelihood and danger of an event weighed against the benefit, or perceived benefit, to a group or society. Examples of acceptable risk are driving a car or flying in an airplane.
Yo! (raises hand) Feeling about the same as when I was unvaxxed. Still staying in hiding as much as possible. I’m a firm believer in Finagle’s Law. Resistentialism for the win.
They do have non mRNA vaccines. The Johnson & Johnson and Astrazeneca are traditional vaccines called “Viral vectors”. There is another vaccine coming soon called Novavax and it is a protein subunit vaccine.
They do have one, but it’s DNA based and has killed a few people vis-a-vis blood clotting. AstraZenica. The mRNA vaccines appear to be remarkably safe and effective. So effective they are probably the future of vaccines.
AZ payload is stored in double-stranded DNA (adenovirus). It’s harmless and bootlegs some of your cells, makes them produce spike proteins like those in covid virus. Your immune system goes WTF, and learns to recognize and whack spikes in the future. Only problem is that AZ isn’t as effective as the mRNA vaccines and is more prone to causing clotting. It will likely be discontinued once there’s enough mRNA vax for everyone.
@Zoe If you are looking for a vaccine that is neither DNA or RNA based then Novavax is for you , but it hasn’t been released yet, but based on trials it is remarkably effective.
@Zoe Here is an article you may want to read. And here is a quote from it…
In this context, the success of the Novavax vaccine should be A1 news. The recent results confirm that it has roughly the same efficacy as the two authorized mRNA vaccines, with the added benefit of being based on an older, more familiar science. The protein-subunit approach used by Novavax was first implemented for the hepatitis B vaccine, which has been used in the U.S. since 1986. The pertussis vaccine, which is required for almost all children in U.S. public schools, is also made this way. Some of those people who have been wary of getting the mRNA vaccines may find Novavax more appealing.